Ossiam’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.67M | Sell |
7,553
-14,917
| -66% | -$4.13M | 0.02% | 328 |
|
|
2026
Q1 | $6.64M | Buy |
22,470
+17,368
| +340% | +$5.16M | 0.12% | 90 |
|
|
2025
Q4 | $1.39M | Sell |
5,102
-4,482
| -47% | -$1.22M | 0.03% | 185 |
|
|
2025
Q3 | $2.59M | Sell |
9,584
-108,145
| -92% | -$29.4M | 0.03% | 299 |
|
|
2025
Q2 | $32.4M | Sell |
117,729
-7,270
| -6% | -$1.98M | 0.36% | 61 |
|
|
2025
Q1 | $33.2M | Buy |
124,999
+114,261
| +1,064% | +$28.2M | 0.46% | 45 |
|
|
2024
Q4 | $2.49M | Sell |
10,738
-106,800
| -91% | -$24.6M | 0.04% | 211 |
|
|
2024
Q3 | $25.9M | Buy |
117,538
+104,413
| +796% | +$21.6M | 0.5% | 47 |
|
|
2024
Q2 | $2.58M | Sell |
13,125
-483
| -4% | -$99.8K | 0.05% | 180 |
|
|
2024
Q1 | $2.93M | Sell |
13,608
-6,128
| -31% | -$1.29M | 0.05% | 197 |
|
|
2023
Q4 | $4.16M | Sell |
19,736
-5,548
| -22% | -$1.18M | 0.07% | 133 |
|
|
2023
Q3 | $5.06M | Buy |
25,284
+5,476
| +28% | +$1.09M | 0.09% | 118 |
|
|
2023
Q2 | $3.67M | Sell |
19,808
-22,719
| -53% | -$4.2M | 0.07% | 154 |
|
|
2023
Q1 | $8.14M | Buy |
42,527
+16,179
| +61% | +$2.93M | 0.17% | 98 |
|
|
2022
Q4 | $4.43M | Buy |
26,348
+13,456
| +104% | +$2.34M | 0.11% | 127 |
|
|
2022
Q3 | $2.28M | Buy |
12,892
+3,159
| +32% | +$624K | 0.07% | 170 |
|
|
2022
Q2 | $1.99M | Sell |
9,733
-305
| -3% | -$64.7K | 0.06% | 164 |
|
|
2022
Q1 | $2.39M | Sell |
10,038
-1,498
| -13% | -$352K | 0.06% | 162 |
|
|
2021
Q4 | $2.64M | Buy |
11,536
+3,160
| +38% | +$695K | 0.07% | 165 |
|
|
2021
Q3 | $1.62M | Sell |
8,376
-1,438
| -15% | -$291K | 0.05% | 197 |
|
|
2021
Q2 | $2.08M | Buy |
9,814
+9,146
| +1,369% | +$1.93M | 0.06% | 183 |
|
|
2021
Q1 | $136K | Sell |
668
-1,583
| -70% | -$312K | ﹤0.01% | 360 |
|
|
2020
Q4 | $410K | Sell |
2,251
-927
| -29% | -$158K | 0.01% | 277 |
|
|
2020
Q3 | $532K | Buy |
3,178
+954
| +43% | +$161K | 0.02% | 241 |
|
|
2020
Q2 | $361K | Sell |
2,224
-5,794
| -72% | -$1.04M | 0.02% | 271 |
|
|
2020
Q1 | $1.39M | Sell |
8,018
-10,981
| -58% | -$2.19M | 0.09% | 149 |
|
|
2019
Q4 | $3.81M | Sell |
18,999
-10,941
| -37% | -$2.24M | 0.29% | 72 |
|
|
2019
Q3 | $6.33M | Buy |
29,940
+16,743
| +127% | +$3.5M | 0.44% | 48 |
|
|
2019
Q2 | $2.56M | Sell |
13,197
-53,503
| -80% | -$9.86M | 0.2% | 106 |
|
|
2019
Q1 | $11M | Buy |
66,700
+1,403
| +2% | +$248K | 0.91% | 24 |
|
|
2018
Q4 | $12.3M | Buy |
+65,297
| New | +$12.1M | 1.85% | 11 |
|
Other funds holding CME
Ossiam's CME Position: Q2 2026 in Review
Ossiam reduced its CME Group (CME) stake by 66% in Q2 2026, selling an estimated $4.13M and leaving 7,553 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #328.
Ossiam first reported a position in CME in Q4 2018 and has held it in 31 quarters since. The position peaked at $33.2M in Q1 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Ossiam held 7,553 shares of CME Group worth $1.67M as of Q2 2026.
- Ossiam sold 14,917 CME Group shares in Q2 2026, an estimated $4.13M.
- CME Group made up 0.02% of Ossiam's portfolio in Q2 2026, its #328 holding.
- Ossiam first reported a position in CME Group in Q4 2018 and has held it in 31 quarters since.
- Ossiam's CME Group position peaked at $33.2M in Q1 2025.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.